The intersection of synthetic biology and visual art has given rise to an innovative field known as bioart. This interdisciplinary collaboration leads to creations that challenge traditional perceptions of both science and art. With advancements in biotechnology, artists can now incorporate living
The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,
NASA’s space biology research grants are shedding light on the profound effects of spaceflight on biological systems, offering invaluable insights into the hazards faced during human space exploration. These grants aim to uncover the intricate biological mechanisms triggered by microgravity,
A groundbreaking study from Arizona State University (ASU) has discovered remarkable insights about a potentially new healing process prompted by necrosis, the premature death of cells. This unexpected phenomenon, observed in fruit flies known for their regenerative capabilities, may have profound
Gene-editing technologies have opened a Pandora's box of possibilities for humanity. These innovations can fundamentally alter human cells and create transformations that range from insignificant to extraordinarily impactful. While such advancements hold immense promise for medical science and
Artis Biosolutions' acquisition of Landmark Bio marks a strategic move designed to bolster cell and gene therapy (CGT) manufacturing capabilities. Landmark Bio, founded by Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Alexandria Real Estate Equities, and Cytiva, has been a key player
